Disease mongering - A challenge for everyone involved in healthcare

British Journal of Clinical Pharmacology

Volumn 64, Issue 2, 2007, Pages 122-124

  Dear, James W ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

COMMERCIAL PHENOMENA; CONSUMER; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; EMOTION; FUNDING; HEALTH CARE; HEALTH SERVICE; HUMAN; HYPERLIPIDEMIA; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; PROFIT; PUBLIC HEALTH; RESPONSIBILITY; RESTLESS LEGS SYNDROME; RISK FACTOR; UNEMPLOYMENT;

COMPLEMENTARY THERAPIES; DRUG INDUSTRY; HUMANS; MARKETING; PERSUASIVE COMMUNICATION;

EID: 34447315579     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02830.x     Document Type: Note

References (13)

1. Applbaum K. Pharmaceutical marketing and the invention of the medical consumer. PLoS Med 2006 3 : e189.
2. Heath I. Combating disease mongering: daunting but nonetheless essential. PLoS Med 2006 3 : e146.
3. Kumar CJ, Deoker A, Kumar A, Kumar A, Hegde BM. Awareness and attitudes about disease mongering among medical and pharmaceutical students. PLoS Med 2006 3 : e213.
4. Lexchin J. Bigger and better: how Pfizer redefined erectile dysfunction. PLoS Med 2006 3 : e132.
5. Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role? PLoS Med 2006 3 : e198.
6. Moynihan R, Henry D. The fight against disease mongering: generating knowledge for action. PLoS Med 2006 3 : e191.
7. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Med 2006 3 : e178.
8. Woloshin S, Schwartz LM. Giving legs to restless legs: a case study of how the media helps make people sick. PLoS Med 2006 3 : e170.
9. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002 324 : 886 91.
10. Dyer O. GSK breached marketing code. BMJ 2006 333 : 368.
11. Guidance on the Code of Practice. Controls on the Promotion of Prescription Medicines in the UK. Available at http://www.abpi.org.uk/ publications/pdfs/PMPCA.pdf (last accessed : 26 June 2006).
12. Funding patient groups. Lancet 2006 368 : 2.
13. Jack A. Too close for comfort? BMJ 2006 333 : 13.